Autologous bone marrow transplantation for Hodgkin's disease

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Autologous bone marrow and/or peripheral blood stem cell transplantation is being performed increasingly frequently as a treatment for Hodgkin's disease. While patients with refractory disease can sometimes be cured, the results are better in patients who are still chemotherapy sensitive. The use of high dose therapy as part of the primary treatment for high risk patients is now being studied.

Original languageEnglish (US)
Pages (from-to)S95-S96
JournalAnnals of Oncology
Issue numberSUPPL. 4
StatePublished - 1992

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Autologous bone marrow transplantation for Hodgkin's disease'. Together they form a unique fingerprint.

Cite this